J Dig Cancer Res.
2020 Jun;8(1):56-60.
Role of Liquid Biopsies in Colorectal Cancer
- Affiliations
-
- 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
Abstract
- In recent years, liquid biopsy has received immense attention. Liquid biopsy is a minimally invasive method used for obtaining biological fluids including urine, pleural fluid and, mostly, peripheral blood. Liquid biopsy involves various targets including circulating tumors cells (CTCs), circulating cell‐free tumor DNA (ctDNA), and microRNA (miRNA). Colorectal cancer (CRC), like other solid tumors, shed tumor cells into the bloodstream. Analysis of these CTCs, as well as ctDNA is the primary objective of the liquid biopsy. Evaluation of CTC or ctDNA offers information about early tumor release, development of tumor metastasis and also about mechanisms involved in tumor resistance to treatment.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Liquid Biopsy: An Emerging Diagnostic, Prognostic, and Predictive Tool in Gastric Cancer
- The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment
- The Analysis of Gallbladder Bile Acid Concentration in Patients with Colorectal Cancer
- Crossroad between inflammation and carcinogenesis in colon
- Obesity-Related Colorectal Cancer: The Role of Leptin
